U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222410) titled 'Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital' on Oct. 23.

Brief Summary: The trial aims to evaluate whether the Airvo 3 device in OptiO2 mode can maintain patients' SpO2 levels within the target range better than manual oxygen titration in hospitalized COPD patients with hypoxemia/respiratory distress.

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: COPD

Intervention: DEVICE: Closed loop oxygen control

Nasal high flow with closed loop oxygen control

DEVICE: Manual titration

Nasal high flow with manual titration

Recruitmen...